Viral oncology: molecular biology and pathogenesis
UN Mui, CT Haley, SK Tyring - Journal of clinical medicine, 2017 - mdpi.com
Oncoviruses are implicated in approximately 12% of all human cancers. A large number of
the world's population harbors at least one of these oncoviruses, but only a small proportion …
the world's population harbors at least one of these oncoviruses, but only a small proportion …
[HTML][HTML] Cervical cancer therapies: Current challenges and future perspectives
Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …
[HTML][HTML] Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit
D Collett, L Mumford, NR Banner, J Neuberger… - American Journal of …, 2010 - Elsevier
An increased incidence of malignancy is an established complication of organ
transplantation and the associated immunosuppression. In this study on cancer incidence in …
transplantation and the associated immunosuppression. In this study on cancer incidence in …
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
Swift elimination of undesirable cells is an important feature in tumour suppression and
immunity. The tumour suppressor p53 and interferon-α and-β (IFN-α/β) are essential for the …
immunity. The tumour suppressor p53 and interferon-α and-β (IFN-α/β) are essential for the …
Rules for making human tumor cells
WC Hahn, RA Weinberg - New England Journal of Medicine, 2002 - Mass Medical Soc
The apparent complexity of the genetic, biochemical, and physiological changes in cancer
cells threatens to stall the elucidation of the origins of cancer and the development of new …
cells threatens to stall the elucidation of the origins of cancer and the development of new …
Pathogenesis of human papillomaviruses in differentiating epithelia
MS Longworth, LA Laimins - Microbiology and molecular biology …, 2004 - Am Soc Microbiol
Human papillomaviruses (HPV) are the etiological agents of cervical and other anogenital
malignancies. Over 100 different types of HPVs have been identified to date, and all target …
malignancies. Over 100 different types of HPVs have been identified to date, and all target …
HPV: Molecular pathways and targets
Infection of high-risk human papillomaviruses (HPVs) is a prerequisite for the development
of cervical carcinoma. HPV infections are also implicated in the development of other types …
of cervical carcinoma. HPV infections are also implicated in the development of other types …
Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review
S Syrjänen, G Lodi, I Von Bültzingslöwen… - Oral …, 2011 - Wiley Online Library
Oral Diseases (2011) 17 (Suppl. 1), 58–72 Objectives: Human papillomavirus (HPV) in oral
carcinoma (OSCC) and potentially malignant disorders (OPMD) is controversial. The primary …
carcinoma (OSCC) and potentially malignant disorders (OPMD) is controversial. The primary …
[图书][B] Asymmetric catalysis on industrial scale: challenges, approaches and solutions
HU Blaser, HJ Federsel - 2011 - books.google.com
This second edition of the pioneering work on this hot topic captures the major trends and
latest achievements in the art of asymmetric catalysis on an industrial scale. A number of …
latest achievements in the art of asymmetric catalysis on an industrial scale. A number of …
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
P Lassen, JG Eriksen, S Hamilton-Dutoit… - Journal of clinical …, 2009 - ascopubs.org
Purpose A subset of head and neck cancers is associated with the human papillomavirus
(HPV). Viral infection is closely correlated with expression of p16INK4A in these tumors. We …
(HPV). Viral infection is closely correlated with expression of p16INK4A in these tumors. We …